A LACK OF DELAYED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS TREATED WITH INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB

Abstract

The incidence of delayed OHT after intravitreal anti-vascular endothelial growth factor injections was low and did not differ between injected and control eyes, including eyes with glaucoma. These results argue against a significant risk of IOP elevation because of repeated anti-vascular endothelial growth factor therapy.